4.7 Article

Influence of MDM2 SNP309 and SNP285 status on the risk of cancer in the breast, prostate, lung and colon

Journal

INTERNATIONAL JOURNAL OF CANCER
Volume 137, Issue 1, Pages 96-103

Publisher

WILEY
DOI: 10.1002/ijc.29358

Keywords

MDM2; SNP309; SNP309 cancer risk

Categories

Funding

  1. Norwegian Cancer Society
  2. Norwegian Health Region West
  3. Bergen Medical Research Foundation

Ask authors/readers for more resources

MDM2 is a key regulator of the p53 tumor suppressor protein and is overexpressed in many human cancers. Two single nucleotide polymorphisms (SNPs) located in the MDM2 intronic promoter (P2) have been found to exert biological function. The G-allele of SNP309T>G; rs2279744 increases MDM2 transcription and has been linked to increased cancer risk. In contrast, the less frequent SNP285G>C; rs117039649, which is in complete linkage disequilibrium with SNP309 (generating a SNP285C/309G variant haplotype), has been related to reduced MDM2 transcription and to reduced risk of breast, endometrial and ovarian cancer. In this large population-based case-control study, we genotyped SNP309 and SNP285 in 10,830 individuals, including cases with cancer of the breast (n=1,717), colon (n=1,532), lung (n=1,331) and prostate (n=2,501), as well as 3,749 non-cancer controls. We found a slightly reduced risk for lung cancer among individuals harboring the SNP309TG/GG genotypes compared to the SNP309TT genotype (OR= 0.86; CI=0.67-0.98), but this association was restricted to women (OR=0.77; CI=0.63-0.95) and was not present among men (OR=0.91; CI=0.77-1.08). Consistent with previous findings, we found a reduced risk for breast cancer among individuals carrying the SNP285GC/309GG genotype versus the SNP285GG/309GG genotype (OR=0.55; CI=0.33-0.93). In conclusion, our data support the hypothesis that the effects of both SNP285 and SNP309 status are tissue dependent.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biotechnology & Applied Microbiology

Impact of MDM2 promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancer

Reham Helwa, Liv B. Gansmo, Merete Bjornslett, Mari Kylleso Halle, Henrica M. J. Werner, Pal Romundstad, Kristian Hveem, Lars Vatten, Anne Dorum, Per E. Lonning, Stian Knappskog

Summary: The study found that the MDM2 SNP55T allele may be associated with a reduced risk of endometrial cancer when combined with the SNP309TT genotype, but not in the context of SNP309G. Additionally, the SNP55T allele was also associated with a reduced risk of endometrial cancer in individuals under 50 years old, regardless of the genotype in neighboring SNPs. No association was observed between SNP55 status and ovarian cancer risk.

BIOMARKERS (2021)

Article Genetics & Heredity

Polymorphisms in the TP53-MDM2-MDM4-axis in patients with rheumatoid arthritis

B. Liv Gansmo, A. Benedicte Lie, Marthe T. Maehlen, Lars Vatten, Pal Romundstad, Kristian Hveem, Per E. Lonning, Stian Knappskog

Summary: The study found a potential association between the MDM2 del1518 variant and the risk of rheumatoid arthritis, as well as indications that combinational genotypes and haplotypes in the MDM2 locus may be related to rheumatoid arthritis.
Article Clinical Neurology

A Clinical Description of Chronic Pain in a General Population Using ICD-10 and ICD-11 (The HUNT Pain Examination Study)

Petter C. Borchgrevink, Mari Glette, Astrid Woodhouse, Stephen Butler, Tormod Landmark, Pal Romundstad, Ola Dale, Tore C. Stiles, Kaare H. Bonaa, Dagfinn Thorsvik, Sabina Thunte, Stein Kaasa

Summary: The purpose of this study was to provide a comprehensive overview, distribution, and ranking of chronic pain conditions in the general population. The findings showed that a higher proportion of participants had chronic pain based on clinical examination compared to self-report in a survey. Among those with examination-verified chronic pain, the majority had chronic primary pain, musculoskeletal pain, and multiple chronic pain conditions. The study also revealed that two-thirds of chronic pain conditions could not be explained by underlying diseases. The most prevalent chronic pain conditions were nonspecific low back pain and neck pain. There was no significant difference in psychopathology between participants with chronic primary pain and chronic secondary pain. Therefore, this study highlights the importance of addressing chronic pain as a public health issue and focusing on prevention and rehabilitation.

JOURNAL OF PAIN (2022)

Article Endocrinology & Metabolism

Simultaneous Quantification of Aromatase Inhibitors and Estrogens in Postmenopausal Breast Cancer Patients

Bjorn-Erik Bertelsen, Kristin Viste, Thomas Helland, Magnus Hagland, Havard Soiland, Jurgen Geisler, Tone Hoel Lende, Per Eystein Lonning, Jorn Sagen, Gunnar Mellgren, Bjorg Almas

Summary: This study developed a liquid chromatography-tandem mass spectrometry (MS/MS) method for simultaneous measurement of serum levels of third-generation aromatase inhibitors (AIs) and ultra-low levels of estrogens. The method is highly valuable for studying drug efficacy and compliance.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Clinical Neurology

Obesity Does Not Protect From Subarachnoid Hemorrhage: Pooled Analyses of 3 Large Prospective Nordic Cohorts

Ilari Rautalin, Jaakko Kaprio, Tor Ingebrigtsen, Pekka Jousilahti, Maja-Lisa Lochen, Pal Richard Romundstad, Veikko Salomaa, Anne Vik, Tom Wilsgaard, Ellisiv B. Mathiesen, Marie Sandvei, Miikka Korja

Summary: The study suggests that a lower body mass index (BMI) is associated with an increased risk of subarachnoid hemorrhage (SAH), while a higher BMI is not significantly associated with SAH risk. However, the increased risk of low BMI is only present in smokers and hypertensive men, but not in nonsmokers or men with normal blood pressure. Therefore, smoking and hypertension may have a modifying effect on the previously reported inverse association between BMI and SAH risk.

STROKE (2022)

Article Multidisciplinary Sciences

Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer

Liv B. Gansmo, Nigar Sofiyeva, Merete Bjornslett, Pal Romundstad, Kristian Hveem, Lars Vatten, Anne Dorum, Per E. Lonning, Stian Knappskog

Summary: The germline deletion of APOBEC3A/B is associated with a reduced risk of ovarian cancer, particularly in non-serous and serous cases. Validation from an independent dataset shows similar trends, with a significant risk reduction observed in clear cell cancers.

SCIENTIFIC REPORTS (2021)

Article Cardiac & Cardiovascular Systems

Ten-Year Cardiovascular Disease Risk Trajectories by Obstetric History: A Longitudinal Study in the Norwegian HUNT Study

Abigail Fraser, Amanda R. Markovitz, Eirin B. Haug, Julie Horn, Pal Richard Romundstad, Havard Dalen, Janet Rich-Edwards, Bjorn Olav Asvold

Summary: Women with a history of obstetric complications have an increased risk of cardiovascular disease, but there is currently no recommendation to specifically target them for CVD screening. However, pregnancy complications can identify women who would benefit from primordial and primary prevention efforts in later life.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Return to Work after Surgical Clipping versus Endovascular Treatment of Unruptured Intracranial Aneurysms: A Nationwide Registry-Based Study

Paulina Majewska, Marie Softeland Sandvei, Sasha Gulati, Tomm B. Mueller, Karen Walseth Hara, Pal Richard Romundstad, Ole Solheim

Summary: This study aimed to assess the return to work after the treatment of unruptured intracranial aneurysms (UIAs). A nationwide registry-based study was conducted in Norway from 2008 to 2018, including adult patients of working age with a record of sickness leave on the day of treatment. The results showed that patients who underwent endovascular treatment returned to work earlier compared to those treated with surgical clipping.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2023)

Article Oncology

APOBEC3A/B deletion polymorphism and endometrial cancer risk

Nigar Sofiyeva, Camilla Krakstad, Mari K. Halle, Tracy A. O'Mara, Pal Romundstad, Kristian Hveem, Lars Vatten, Per E. Lonning, Liv B. Gansmo, Stian Knappskog

Summary: The APOBEC3A/B deletion variant is associated with a decreased risk of endometrial cancer in Norwegian women.

CANCER MEDICINE (2023)

Article Oncology

Molecular and phenotypic characteristics influencing the degree of cytoreduction in high-grade serous ovarian carcinomas

Cecilie Fredvik Torkildsen, Liv Cecilie Vestrheim Thomsen, Ragnar Kvie Sande, Camilla Krakstad, Ingunn Stefansson, Eva Karin Lamark, Stian Knappskog, Line Bjorge

Summary: In this study, phenotypic markers were combined with targeted DNA sequencing to discover novel biomarkers for guiding surgical management in high-grade serous ovarian carcinoma (HGSOC) patients. The study highlights the potential of a preoperative risk stratification model combining phenotypic traits and single-gene mutational status in predicting surgical outcomes.

CANCER MEDICINE (2023)

Article Cardiac & Cardiovascular Systems

Insight into the relationship between resting heart rate and atrial fibrillation: a Mendelian randomization study

Marie Klevjer, Humaira Rasheed, Pal R. Romundstad, Erik Madssen, Ben M. Brumpton, Anja Bye

Summary: This study used Mendelian randomization to explore the causal association between resting heart rate (RHR) and atrial fibrillation (AF), and found an inverse causal relationship between them, especially when RHR was below 90 beats per minute. The results challenge the current observational knowledge on RHR and AF.

EUROPACE (2023)

Article Oncology

Anal cancer screening results from 18-to-34-year-old men who have sex with men living with HIV

Yuxin Liu, Swati Bhardwaj, Keith Sigel, John Winters, Joseph Terlizzi, Michael M. Gaisa

Summary: This study investigated the prevalence and severity of anal HPV disease among MSM LWH under the age of 35, finding a high prevalence of HPV infection and precancer but no cases of invasive anal cancer. This supports the adoption of age-based anal cancer screening for this population.

INTERNATIONAL JOURNAL OF CANCER (2024)